Arvee Laboratories India Ltd
Fundamental Score
Arvee Laboratories India Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of ARVEE across key market metrics for learning purposes.
Positive Indicators
3 factors identified
Conservative Debt Levels (D/E: 0.03)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.
Balanced Promoter Holding (73.50%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
12 factors identified
Below-Average Return on Equity (7.12%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Premium Valuation Risk (P/E: 440.10x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations. Consider entry timing carefully.
Profit Decline Concern (-98.98%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes. Monitor for recovery signs and management guidance.
Revenue Contraction (-72.47%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions and competitive positioning. Monitor recovery strategies.
Limited Growth History (-3.26% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities. Assess future growth catalysts.
Weak Earnings Growth (-0.13% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation. Consider growth catalysts and competitive positioning.
Stagnant Profit Growth (-0.09% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity. Assess transformation initiatives.
Negative Free Cash Flow (₹-1.56 Cr over 5Y)
Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.
Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
High P/E Ratio
Observation: Stock may be overvalued relative to earnings.
Analysis: P/E above 30 requires strong growth execution to justify current valuations.
Very High P/E Ratio
Observation: Significant overvaluation risk present.
Analysis: Extremely high P/E ratios indicate potential bubble territory and high downside risk.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Financial Statements
Comprehensive financial data for Arvee Laboratories India Ltd
About ARVEE
Business Overview
Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company offers polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, and dimethyl 5-aminoisophthalate, as well as 3,5-dinitrobenzoic acid and 3,5-diamino benzoic acid. It also provides drug intermediates comprising 2-acetyl thiophene, thiophene-2-carboxaldehyde, 4amino pyridine, and 2chloro5nitrobenzoic acid. In addition, the company exports its products. Arvee Laboratories (India) Ltd. was incorporated in 2012 and is based in Ahmedabad, India.
Company Details
Key Leadership
ARVEE Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Arvee Laboratories India Ltd (ARVEE)?
As of 30 Jan 2026, 01:37 pm IST, Arvee Laboratories India Ltd (ARVEE) is currently trading at ₹156.88. The stock has a market capitalization of ₹176.04 (Cr).
Is ARVEE share price Overvalued or Undervalued?
ARVEE is currently trading at a P/E ratio of 440.10x, compared to the industry average of 29.20x. Based on this relative valuation, the stock appears to be Overvalued against its sector peers.
What factors affect the Arvee Laboratories India Ltd share price?
Key factors influencing ARVEE's price include its quarterly earnings growth (Sales Growth: -72.47%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Arvee Laboratories India Ltd a good stock for long-term investment?
Arvee Laboratories India Ltd shows a 5-year Profit Growth of -0.09% and an ROE of 7.12%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.03 before investing.
How does Arvee Laboratories India Ltd compare with its industry peers?
Arvee Laboratories India Ltd competes with major peers in the Specialty Chemicals. Investors should compare ARVEE's P/E of 440.10x and ROE of 7.12% against the industry averages to determine its competitive standing.
What is the P/E ratio of ARVEE and what does it mean?
ARVEE has a P/E ratio of 440.10x compared to the industry average of 29.20x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹440 for every ₹1 of annual earnings.
How is ARVEE performing according to Bull Run's analysis?
ARVEE has a Bull Run fundamental score of 15.9/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does ARVEE belong to?
ARVEE operates in the Specialty Chemicals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Arvee Laboratories India Ltd.
What is Return on Equity (ROE) and why is it important for ARVEE?
ARVEE has an ROE of 7.12%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Arvee Laboratories India Ltd generates profits from shareholders' equity.
How is ARVEE's debt-to-equity ratio and what does it indicate?
ARVEE has a debt-to-equity ratio of 0.03, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.
What is ARVEE's dividend yield and is it a good dividend stock?
ARVEE offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.
How has ARVEE grown over the past 5 years?
ARVEE has achieved 5-year growth rates of: Sales Growth -3.26%, Profit Growth -0.09%, and EPS Growth -0.13%.
What is the promoter holding in ARVEE and why does it matter?
Promoters hold 73.50% of ARVEE shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is ARVEE's market capitalization category?
ARVEE has a market capitalization of ₹176 crores, placing it in the Small-cap category.
How volatile is ARVEE stock?
ARVEE has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for ARVEE?
ARVEE has a 52-week high of ₹N/A and low of ₹N/A.
What is ARVEE's operating profit margin trend?
ARVEE has a 5-year average Operating Profit Margin (OPM) of 11.74%, indicating the company's operational efficiency.
How is ARVEE's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of -72.47% and YoY Profit Growth of -98.98%.
What is the institutional holding pattern in ARVEE?
ARVEE has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.